NCT01188681 2021-06-10Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic LeukemiaAptevo TherapeuticsPhase 1/2 Completed79 enrolled 13 charts
NCT01317901 2017-06-28A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent LymphomaAptevo TherapeuticsPhase 1 Completed12 enrolled 15 charts